Life Extension Final Clerance Sale

Life Extension Magazine

LE Magazine May 2003

image

Improve Your Sex Life And
Protect Against Heart Attack
By J. Phillip Vogel


References

1. Wysowski DK, et al. Use of medications for erectile dysfunction in the United States, 1996 through 2001. J Urol 2003 Mar;169(3):1040-2.

2. Bairey Merz CN, et al. Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women’s Ischemia Syndrome Evaluation (WISE). Am J Med 2002 Dec 15;113(9):723-7.

3. Pugh PJ, et al. Testosterone: a natural tonic for the failing heart. QJ Med 2000; 93:689-694.

4. Gray A, et al. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991 Nov;73(5):1016-25.

5. de Lignieres B. Andropause and its management in the aged male. Presse Med 2002 Nov 23;31(37 Pt 1):1750-9.

6. Channer KS, et al. Cardiovascular effects of testosterone: implications of the “male menopause”? Heart 2003 Feb;89(2):121-2.

7. Gruenewald DA, et al. Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks. J Am Geriatr Soc 2003 Jan;51(1):101-115.

8. de Kruif P. The Male Hormone. New York:Harcourt, Brace and Company; 1945.

9. Malgor LA, et al. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide. Acta Physiol Pharmacol Ther Latinoam 1998;48(2):99-105

10. Szulc P, et al. Osteoporosis in the aged male. Presse Med 2002 Nov 23;31(37 Pt 1):1760-9.

11. Gruenewald DA, et al. Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks. J Am Geriatr Soc 2003 Jan;51(1):101-115.

12. Ettinger SM. Myocardial infarction and unstable angina: gender differences in therapy and outcomes. Curr Womens Health Rep 2003 Apr;3(2):140-8.

13. Friedl KE, et al. High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered. Metabolism 1990 Jan;39(1):69-74.

14. Heald AH, et al. Significant ethnic variation in total and free testosterone concentration. Clin Endocrinol (Oxf) 2003 Mar;58(3):262-6.

15. Rioufol G, et al. Arch Mal Coeur Vaiss 2002 Dec;95(12):1210-4.

16. Wright, J, et al. Maximize you Vitality & Potency. California: Smart Publications. 1999. 120

17. Wright, J, et al. Maximize you Vitality & Potency. California: Smart Publications. 1999. 120

18. Brevetti G, et al. Intermittent claudication: pharmacoeconomic and quality-of-life aspects of treatment. Pharmacoeconomics 2002;20(3):169-81.

19. Jaegere Pd P, et al. Long-term clinical outcome after stent implantation in coronary arteries. Int J Cardiovasc Intervent 1999;2(1):27-34.

20. Honderick T, et al. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. Am J Emerg Med 2003 Jan;21(1):39-42.

21. Moller J, et al. Testosterone treatment of cardiovascular diseases. Berlin:Springer-Verlag; 1984.

22. Lesser M. Testosterone propionate therapy in one hundred cases of angina pectoris. J Clin Endocrinol. 1946;6:549-557.

23. Izumi S, et al. Improvement of peripheral neuropathy by testosterone in a patient with 48,XXYY syndrome. Tokai J Exp Clin Med 2000 Jun;25(2):39-44.

24. Phillips GB, et al. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994;14:701-6.

25. Hak AE, et al. Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002 Aug;87(8):3632-9.

26. Tsujimura A, et al. The clinical studies of sildenafil for the ageing male. Int J Androl 2002 Feb;25(1):28-33.

27. Gruenewald DA, et al. Testosterone Supplementation Therapy for Older Men: Potential Benefits and Risks. J Am Geriatr Soc 2003 Jan;51(1):101-115.

28. Kontoleon PE, et al. Hormonal profile in patients with congestive heart failure. Int J Cardiol 2003 Feb;87(2-3):179-83.

29. Knowlton AA, et al. Heat-shock factor-1, steroid hormones, and regulation of heat-shock protein expression in the heart. Am J Physiol Heart Circ Physiol 2001 Jan;280(1):H455-64.

30. Kaczmarek A, et al. The association of lower testosterone level with coronary artery disease in postmenopausal women. Int J Cardiol 2003 Jan;87(1):53-7.

31. Allolio B, et al. Osteoporosis in the male. Med Klin 2000 Jun 15;95(6):327-38.

32. Szulc P, et al. Osteoporosis in the aged male. Presse Med 2002 Nov 23;31(37 Pt 1):1760-9.

33. Weinreb M, et al. Histomorphometrical analysis of the effects of the bisphosphonate alendronate on bone loss caused by experimental periodontitis in monkeys. J Periodontal Res 1994 Jan;29(1):35-40.

34. Pope HG, et al. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 2003 Jan;160(1):105-11.

35. Testosterone and depression in men. Treatment update 2000 May;12(3):7-8.

36. Perry PJ, et al. Testosterone therapy in late-life major depression in males. J Clin Psychiatry 2002 Dec;63(12):1096-101.

37. Cohen PG. Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypotheses 2001 Jun;56(6):702-8

38. Zumoff B. Hormonal abnormalities in obesity. Acta Med Scand Suppl 1988;723:153-60.

39. Vermeulen A, et al. Estradiol in elderly men. Aging Male 2002 Jun;5(2):98-102.

40. Novak A, et al. Andropause and quality of life: findings from patient focus groups and clinical experts. Maturitas 2002 Dec 10;43(4):231-7.

41. Padula GD et al. Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002 Feb 1;52(2):439-43.

42. Wu CY, et al. Age related testosterone level changes and male andropause syndrome. Changgeng Yi Xue Za Zhi 2000 Jun;23(6):348-53.

43. Vermeulen A, et al. Neuroendocrinological aspects of aging. Verh K Acad Geneeskd Belg 1994;56(4):267-80.

44. Amory JK, et al. Endocrine regulation of testicular function in men: implications for contraceptive development. Mol Cell Endocrinol 2001 Sep;182(2):175-9.

45. Vermeulen A, et al. Estradiol in elderly men. Aging Male 2002 Jun;5(2):98-102.

46. Rudzinski W, et al. Effects of estrogens on the brain and implications for neuro-protection. Neurol Neurochir Pol 2002 Jan-Feb;36(1):143-56.

47. McConnell JD, et al. Androgen ablation and blockade in the treatment of benign prostatic hyperplasia. Urol Clin North Am 1990 Aug;17(3):661-70.

48. Crook JM, et al. Intermittent androgen suppression in the management of prostate cancer. Urology 1999 Mar;53(3):530-4.

49. Kellis JT, et al. Inhibition of human estrogen synthetase (aromatase) by flavones. Science 1984 Sep 7;225(4666):1032-4.

50. Dhawan K, et al. Beneficial effects of chrysin and benzoflavone on virility in 2-year-old male rats. J Med Food 2002 Spring;5(1):43-8.

51. Legssyer A, et al. Cardiovascular effects of Urtica dioica L. in isolated rat heart and aorta. Phytother Res 2002 Sep;16(6):503-7.

52. Schottner M, et al. Lignans from the roots of Urtica dioica and their metabolites bind to human sex hormone binding globulin (SHBG). Planta Med 1997 Dec;63(6):529-32.

53. Waynberg J, et al. Effects of Herbal vX on libido and sexual activity in premenopausal and postmenopausal women. Adv Ther 2000 Sep-Oct;17(5):255-62.

54. Wright, J, et al. Maximize you Vitality & Potency. California: Smart Publications. 1999;113.

55. Waynberg J. Aphrodisiacs: Contributions to the clinical evaluation of the taditional use of Ptychopetalum. The First International Congress on Ethnopharmacology, France, June, 1990.

image

Back to the Magazine Forum